AI assistant
Sending…
PFIZER INC — Director's Dealing 2011
Feb 10, 2011
29831_dirs_2011-02-09_a28ca9c0-e506-4570-940d-2390177b8b78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: KING PHARMACEUTICALS INC (KG)
CIK: 0001047699
Period of Report: 2011-01-31
Reporting Person: PFIZER INC (10% Owner)
Reporting Person: Parker Tennessee Corp. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, no par value | 230719938 | Indirect |
Footnotes
F1: Reflects shares purchased by Parker Tennessee Corp. ("Purchaser"), a wholly-owned subsidiary of Pfizer Inc. ("Parent"), in a tender offer.
F2: The shares are owned directly by Purchaser. The shares may also be deemed to be indirectly beneficially owned by Parent.
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31